278 related articles for article (PubMed ID: 26799480)
1. Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs.
Gelato KA; Adler D; Ocker M; Haendler B
Expert Opin Ther Targets; 2016 Jul; 20(7):783-99. PubMed ID: 26799480
[TBL] [Abstract][Full Text] [Related]
2. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
Morera L; Lübbert M; Jung M
Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
[TBL] [Abstract][Full Text] [Related]
3. Targeting Histone Methylation in Cancer.
McCabe MT; Mohammad HP; Barbash O; Kruger RG
Cancer J; 2017; 23(5):292-301. PubMed ID: 28926430
[TBL] [Abstract][Full Text] [Related]
4. Novel combination of histone methylation modulators with therapeutic synergy against acute myeloid leukemia in vitro and in vivo.
Wen S; Wang J; Liu P; Li Y; Lu W; Hu Y; Liu J; He Z; Huang P
Cancer Lett; 2018 Jan; 413():35-45. PubMed ID: 29069576
[TBL] [Abstract][Full Text] [Related]
5. BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer.
Genta S; Pirosa MC; Stathis A
Curr Oncol Rep; 2019 Feb; 21(2):13. PubMed ID: 30715616
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic small molecule modulators of histone and DNA methylation.
Hauser AT; Robaa D; Jung M
Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
[TBL] [Abstract][Full Text] [Related]
7. Impact of Epigenetic Regulation on Head and Neck Squamous Cell Carcinoma.
Bais MV
J Dent Res; 2019 Mar; 98(3):268-276. PubMed ID: 30615537
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic cancer therapy: Proof of concept and remaining challenges.
Mund C; Lyko F
Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.
Hosseini A; Minucci S
Epigenomics; 2017 Aug; 9(8):1123-1142. PubMed ID: 28699367
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
11. Emerging epigenetic targets and therapies in cancer medicine.
Popovic R; Licht JD
Cancer Discov; 2012 May; 2(5):405-13. PubMed ID: 22588878
[TBL] [Abstract][Full Text] [Related]
12. Targeting protein lysine methylation and demethylation in cancers.
He Y; Korboukh I; Jin J; Huang J
Acta Biochim Biophys Sin (Shanghai); 2012 Jan; 44(1):70-9. PubMed ID: 22194015
[TBL] [Abstract][Full Text] [Related]
13. Targeting epigenetic regulators for cancer therapy.
Wee S; Dhanak D; Li H; Armstrong SA; Copeland RA; Sims R; Baylin SB; Liu XS; Schweizer L
Ann N Y Acad Sci; 2014 Feb; 1309():30-6. PubMed ID: 24571255
[TBL] [Abstract][Full Text] [Related]
14. The emerging roles of histone demethylases in cancers.
Tong D; Tang Y; Zhong P
Cancer Metastasis Rev; 2024 Jun; 43(2):795-821. PubMed ID: 38227150
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between epigenetics and metabolism-Yin and Yang of histone demethylases and methyltransferases in cancer.
Filipp FV
Brief Funct Genomics; 2017 Nov; 16(6):320-325. PubMed ID: 28369194
[TBL] [Abstract][Full Text] [Related]
16. Targeting histone lysine methylation in cancer.
McGrath J; Trojer P
Pharmacol Ther; 2015 Jun; 150():1-22. PubMed ID: 25578037
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Regulation of p21
Ocker M; Bitar SA; Monteiro AC; Gali-Muhtasib H; Schneider-Stock R
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31514410
[TBL] [Abstract][Full Text] [Related]
18. Targeting the histone orthography of cancer: drugs for writers, erasers and readers.
Simó-Riudalbas L; Esteller M
Br J Pharmacol; 2015 Jun; 172(11):2716-32. PubMed ID: 25039449
[TBL] [Abstract][Full Text] [Related]
19. The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review.
Rugo HS; Jacobs I; Sharma S; Scappaticci F; Paul TA; Jensen-Pergakes K; Malouf GG
Adv Ther; 2020 Jul; 37(7):3059-3082. PubMed ID: 32445185
[TBL] [Abstract][Full Text] [Related]
20. Cancer epigenetics drug discovery and development: the challenge of hitting the mark.
Campbell RM; Tummino PJ
J Clin Invest; 2014 Jan; 124(1):64-9. PubMed ID: 24382391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
